Patent details

EP2268267 Title: DRY TRANSGLUTAMINASE COMPOSITION

Basic Information

Publication number:
EP2268267
PCT Application Number:
EP2009054657
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP097351639
PCT Publication Number:
WO2009130181
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
DRY TRANSGLUTAMINASE COMPOSITION
French Title of Invention:
COMPOSITION DE TRANSGLUTAMINASE SÈCHE
German Title of Invention:
TROCKENE TRANSGLUTAMINASE-ZUSAMMENSETZUNG
SPC Number:

Dates

Filing date:
20/04/2009
Grant date:
14/06/2017
EP Publication Date:
05/01/2011
PCT Publication Date:
29/10/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
14/06/2017
EP B1 Publication Date:
14/06/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
20/04/2018
Expiration date:
20/04/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
14/06/2017
 
 

Name:
Novo Nordisk Health Care AG
Address:
Thurgauerstrasse 36/38, 8050 Zürich, Switzerland (CH)

Inventor

1

Name:
FALCK, Thomas
Address:
Denmark (DK)

2

Name:
BRADER, Mark
Address:
Denmark (DK)

3

Name:
KRISTIANSEN, Gunhild Klarskov
Address:
Denmark (DK)

Priority

Priority Number:
08103642
Priority Date:
21/04/2008
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 9/19; A61K 38/45; C12N 9/10;

Publication

European Patent Bulletin

Issue number:
201724
Publication date:
14/06/2017
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
30/08/2018 Outgoing Correspondence 1